Llwytho...
Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
PURPOSE: To describe the effect of tocilizumab in two patients with thyroid associated orbitopathy (TAO). OBSERVATIONS: We present two patients with TAO who could not tolerate corticosteroids and had a reduction in clinical and laboratory markers of inflammatory activity with subsequent tocilizumab...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Am J Ophthalmol Case Rep |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722155/ https://ncbi.nlm.nih.gov/pubmed/29260102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2017.07.001 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|